BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24465802)

  • 1. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
    Javle M; Li Y; Tan D; Dong X; Chang P; Kar S; Li D
    PLoS One; 2014; 9(1):e85942. PubMed ID: 24465802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer.
    Lampropoulos P; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
    Tumour Biol; 2012 Aug; 33(4):1005-14. PubMed ID: 22278155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
    Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
    Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
    Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
    Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of the expression of Smad4, transforming growth factor beta(1) and beta receptor II proteins in paraffin-embedded human pancreatic cancer tissues].
    Gu L; Chen J; Liu T; Li L; Lu Z; Luo Y
    Zhonghua Bing Li Xue Za Zhi; 2001 Dec; 30(6):439-42. PubMed ID: 11866987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Par-4 mediated Smad4 induction in PDAC cells restores canonical TGF-β/ Smad4 axis driving the cells towards lethal EMT.
    Mohd Faheem M; Rasool RU; Ahmad SM; Jamwal VL; Chakraborty S; Katoch A; Gandhi SG; Bhagat M; Goswami A
    Eur J Cell Biol; 2020 May; 99(4):151076. PubMed ID: 32439219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.
    Liang C; Xu J; Meng Q; Zhang B; Liu J; Hua J; Zhang Y; Shi S; Yu X
    Autophagy; 2020 Mar; 16(3):486-500. PubMed ID: 31177911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatase PPM1A is a novel prognostic marker in pancreatic ductal adenocarcinoma.
    Fan J; Yang MX; Ouyang Q; Fu D; Xu Z; Liu X; Mino-Kenudson M; Geng J; Tang F
    Hum Pathol; 2016 Sep; 55():151-8. PubMed ID: 27195906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kindlin-2 induced by TGF-β signaling promotes pancreatic ductal adenocarcinoma progression through downregulation of transcriptional factor HOXB9.
    Zhan J; Song J; Wang P; Chi X; Wang Y; Guo Y; Fang W; Zhang H
    Cancer Lett; 2015 May; 361(1):75-85. PubMed ID: 25724625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis.
    Yasutome M; Gunn J; Korc M
    Clin Exp Metastasis; 2005; 22(6):461-73. PubMed ID: 16320109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.
    Torbenson M; Marinopoulos S; Dang DT; Choti M; Ashfaq R; Maitra A; Boitnott J; Wilentz RE
    Hum Pathol; 2002 Sep; 33(9):871-6. PubMed ID: 12378510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poorly differentiated histologic grade correlates with worse survival in SMAD4 negative pancreatic adenocarcinoma patients.
    Park JY; King J; Reber H; Joe Hines O; Mederos MA; Wang HL; Dawson D; Wainberg Z; Donahue T; Girgis M
    J Surg Oncol; 2021 Feb; 123(2):389-398. PubMed ID: 33146409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
    Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
    World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.
    Ijichi H; Chytil A; Gorska AE; Aakre ME; Fujitani Y; Fujitani S; Wright CV; Moses HL
    Genes Dev; 2006 Nov; 20(22):3147-60. PubMed ID: 17114585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.
    Figueroa JD; Flanders KC; Garcia-Closas M; Anderson WF; Yang XR; Matsuno RK; Duggan MA; Pfeiffer RM; Ooshima A; Cornelison R; Gierach GL; Brinton LA; Lissowska J; Peplonska B; Wakefield LM; Sherman ME
    Breast Cancer Res Treat; 2010 Jun; 121(3):727-35. PubMed ID: 19937272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells.
    Chen YW; Hsiao PJ; Weng CC; Kuo KK; Kuo TL; Wu DC; Hung WC; Cheng KH
    BMC Cancer; 2014 Mar; 14():181. PubMed ID: 24625091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of TGF-beta1, its receptor TGFbetaRII, and Smad proteins in the progression of colorectal cancer.
    Gulubova M; Manolova I; Ananiev J; Julianov A; Yovchev Y; Peeva K
    Int J Colorectal Dis; 2010 May; 25(5):591-9. PubMed ID: 20165854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.